Roche Holding AG
已核验 OTC 代码：RHHBY；证券类型：美国存托凭证（ADR）。
本页读取既有公司身份及官方来源登记，不推定或补填 SEC CIK。身份核验：2026-10-21T05:20:17.780Z；证券类型核验：2026-10-21T05:20:17.780Z。
公司公告不代表平台项目、在售壳或平台背书。
已核验官方动态
- 2026-10-19 · Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio
- 2026-10-16 · FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
- 2026-10-09 · FDA approves Roche’s Tecentriq in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer
- 2026-09-23 · Change in Roche’s Board of Directors
- 2026-09-21 · European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)